Browse by all authors Browse By Author Name - Bochner,+F.

Browse Results (7 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Ravenscroft, P.J., Charles, B.G., Sligo, J. and Bochner, F. (1981). A comparison of the bioavailability of theophylline liquids and tablets. In: Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists. 14th Annual Meeting of the Australasian Society of Clinical and Experimental Pharmacologists, Canberra, ACT, Australia, (657-657). December 1980. doi:10.1111/j.1440-1681.1981.tb00772.x 47   0 0
Charles, B. G., Ravenscroft, P. J. and Bochner, F. (1980) Comparative bioavailability study of theophylline tablets marketed in Australasia. Medical Journal of Australia, 2 5: 264-266. 55   3 Cited 0 times in Scopus0
Heazlewood, VJ, Galligan, JP, Cannell, GR, Mortimer, RH and Bochner, F (1982). Cortisol Delivery From Cortisone-Acetate Administration and Cortisol Pharmacokinetics in Patients with Addisons-Disease and Hypopituitarism. In: Clinical and Experimental Pharmacology and Physiology. , , (402-403). . 30   0
Cham, BE, Bochner, F, Imhoff, DM, Byrne, G and Gunsberg, M (1982) Invivo and Invitro Studies On the Binding of Salicylate to Human-Plasma Proteins - Evidence for One Type of Binding-Site. Journal of Pharmacology and Experimental Therapeutics, 220 3: 648-653. 22   5
McKauge, L, Bochner, F, Eadie, MJ and Tyrer, JH (1979). Plasma Carbamazepine-10,11-Epoxide Levels in Epileptic Patients. In: Clinical and Experimental Pharmacology and Physiology. , , (212-212). . 18   0
Heazelwood, VJ, Galligan, JP, Cannell, GR, Bochner, F and Mortimer, RH (1984) Plasma-Cortisol Delivery From Oral Cortisol and Cortisone-Acetate - Relative Bioavailability. British Journal of Clinical Pharmacology, 17 1: 55-59. 21   25
Imhoff, D, Bochner, F, Gunsberg, M, Graham, G, Parsons, G, Cham, B and Byrne, G (1982). Salicylates in Rheumatoid Disease. In: Clinical and Experimental Pharmacology and Physiology. , , (460-461). . 15   0